Charles Schwab Investment Management Inc Day One Biopharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 528,148 shares of DAWN stock, worth $3.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

528,148

Previous 535,501 1.37%

Holding current value

$3.49 Million

Previous $6.78 Million 38.27%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$7.93 - $13.21 $58,309 - $97,133	-7,353 Reduced 1.37%	528,148 $4.19 Million
Q4 2024 Feb 06, 2025	BUY	$12.46 - $16.39 $349,540 - $459,788	28,053 Added 5.53%	535,501 $6.78 Million
Q3 2024 Nov 12, 2024	BUY	$12.72 - $16.03 $822,984 - $1.04 Million	64,700 Added 14.61%	507,448 $7.07 Million
Q2 2024 Aug 12, 2024	SELL	$12.03 - $17.69 $179,295 - $263,651	-14,904 Reduced 3.26%	442,748 $6.1 Million
Q1 2024 May 08, 2024	BUY	$13.56 - $17.46 $63,976 - $82,376	4,718 Added 1.04%	457,652 $7.56 Million
Q4 2023 Feb 06, 2024	BUY	$9.68 - $15.37 $56,105 - $89,084	5,796 Added 1.3%	452,934 $6.61 Million
Q3 2023 Nov 08, 2023	BUY	$11.22 - $14.86 $1.4 Million - $1.86 Million	125,050 Added 38.82%	447,138 $5.49 Million
Q2 2023 Aug 09, 2023	BUY	$11.74 - $14.47 $1.4 Million - $1.73 Million	119,421 Added 58.92%	322,088 $3.85 Million
Q1 2023 May 11, 2023	SELL	$12.75 - $23.41 $15,784 - $28,981	-1,238 Reduced 0.61%	202,667 $2.71 Million
Q4 2022 Feb 13, 2023	BUY	$18.77 - $22.0 $92,967 - $108,966	4,953 Added 2.49%	203,905 $4.39 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $754,743 - $1.22 Million	45,909 Added 30.0%	198,952 $3.99 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $17.9 $280,331 - $877,261	49,009 Added 47.11%	153,043 $2.74 Million
Q1 2022 May 13, 2022	BUY	$9.12 - $17.47 $254,137 - $486,819	27,866 Added 36.58%	104,034 $1.03 Million
Q4 2021 Feb 11, 2022	BUY	$15.65 - $26.33 $14,742 - $24,802	942 Added 1.25%	76,168 $1.28 Million
Q3 2021 Nov 16, 2021	BUY	$20.0 - $27.92 $1.5 Million - $2.1 Million	75,226 New	75,226 $1.79 Million

Others Institutions Holding DAWN

# of Institutions

196

Shares Held

76.7M

Call Options Held

138K

Put Options Held

208K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $486M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Day One Biopharmaceuticals, Inc. Transaction History